Enfuvirtide
Specialist research
It was developed for treatment experienced HIV-1 infection; TORO studies found improved short term virologic response when added to optimized background therapy, with resistance associated gp41 substitutions documented.
An authorisation applies to at least one defined finished product in a stated jurisdiction; it does not apply automatically to this catalogue material.
What is Enfuvirtide?
Enfuvirtide is a synthetic peptide fusion inhibitor targeting HIV type 1 gp41 used in antiviral and resistance research; the catalogue label denotes the research grade peptide employed in virology studies.
Which research context has Enfuvirtide been associated with?
Enfuvirtide is associated with specialist antiviral research as a synthetic HIV type 1 fusion inhibitor peptide targeting gp41 mediated membrane fusion; clinical trials (TORO) assessed its addition to optimized background therapy and documented resistance associated gp41 substitutions.
What documentation is available for Enfuvirtide?
Enfuvirtide: Batch documents are not yet linked on this site. For this synthetic HIV type 1 fusion inhibitor peptide expected evidence includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity specification; peptide content, counterion and residual solvent/water declaration; and validated potency/assay method used for release testing. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Enfuvirtide?
Enfuvirtide: Storage depends on the documented supplied presentation; as a synthetic HIV type 1 fusion inhibitor peptide verify whether supplied dry/lyophilised or in solution, counterion and concentration, solvent or buffer composition, pH sensitivity, container closure interactions, freeze/thaw behaviour and aggregation propensity for this longer peptide. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.